{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-108935","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2026-09-18T20:05:35+00:00","discovered_at":"2026-09-18T20:07:01.069774+00:00","generated_at":"2026-09-18T20:07:21.314564+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"TELA Bio faces Nasdaq delisting over bid price; plans hearing and reverse split","bullets":["Nasdaq notified TELA Bio on 9/15/26 it is subject to delisting for failing $1.00 minimum bid price rule.","Company intends to request a Nasdaq Hearings Panel hearing, which will stay any suspension pending outcome.","Filed proxy for reverse stock split (1-for-5 to 1-for-15) to regain bid price compliance; special meeting 10/8/26.","No assurance stockholders approve reverse split; delisting risk persists if not approved or price not sustained."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-108935","json":"https://secwatch.observer/filing/0001104659-26-108935.json","markdown":"https://secwatch.observer/filing/0001104659-26-108935.md","text":"https://secwatch.observer/filing/0001104659-26-108935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926108935/0001104659-26-108935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926108935/tm2625586d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T20:07:21.314564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}